Empowered Patient Podcast

Welcome to the Empowered Patient Podcast with Karen Jagoda. This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape. Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes Value-based healthcare Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Implantable Blood Glucose Monitors Provide Years of Accurate Monitoring with Paul Goode Glucotrack TRANSCRIPT

Download PDF

Jan 19, 2026

Paul Goode, President and CEO of Glucotrack, discusses the evolution and future of continuous glucose and continuous blood glucose monitoring for people with diabetes, as well as opportunities for implantable CMG monitors. In addition to convenience and comfort, the Glucotrack implantable CGM monitor is designed to be...

Implantable Blood Glucose Monitors Provide Years of Accurate Monitoring with Paul Goode Glucotrack

Jan 19, 2026

Targeting Elevated Cortisol Seen as a Hidden Driver of Treatment-Resistant Type 2 Diabetes with Robert Jacks Sparrow Pharmaceuticals TRANSCRIPT

Download PDF

Dec 10, 2025

Robert Jacks, President and CEO of Sparrow Pharmaceuticals, identifies that an elevated cortisol level is a newly recognized cause of treatment-resistant type 2 diabetes. A significant portion of patients with diabetes who do not respond to standard treatments, including GLP-1 agonists, have underlying high cortisol....

Targeting Elevated Cortisol Seen as a Hidden Driver of Treatment-Resistant Type 2 Diabetes with Robert Jacks Sparrow Pharmaceuticals

Dec 10, 2025

Medical Food Shows Impact on Diabetic Peripheral Neuropathy with Amanda Wiggins cGP Lab TRANSCRIPT

Download PDF

Jul 9, 2025

Amanda Wiggins is CEO of cGP Lab, a New Zealand-based company that is commercializing cycline Glycine Proline, cGP, a dipeptide molecule that helps regulate blood vessel formation. The Lab is pursuing a medical food regulatory pathway to bring its cGP-based products to the market for the dietary management of...